NBY News and Press, NovaBay Pharmaceuticals Inc. From 12/13/21

NovaBay ® Pharmaceuticals, Inc . (NYSE American: NBY), a pharmaceutical company focused on developing and commercializing high-quality, scientifically formulated products for the eyecare and skincare markets, announces that DERMAdoctor’s Calm Cool + Corrected 1% Coll...

Penny Stocks Insiders Decided To Buy In December 2021 Penny stocks are a great way to make money in the stock market without waiting years for a return. Even though they’ve got more risk to account for, the way traders can leverage smaller sums of capital to reap hefty gains isn&...

New African Virus Variant Puts These Penny Stocks In The Spotlight Today What’s going on in the stock market today? Earlier this week, we were heading into the holiday nearing record-high levels. Countless penny stocks were red hot, and retail traders were reaping the rewards...

NovaBay ® Pharmaceuticals, Inc . (NYSE American: NBY) announces that Chief Executive Officer Justin Hall has issued the following Letter to Stockholders: To My Fellow Stockholders: The purpose of this letter is to share some of my personal thoughts about NovaBay and...

NovaBay Pharmaceuticals, Inc. (NBY) Q3 2021 Earnings Conference Call November 11, 2021 4:30 PM ET Company Participants Jody Cain – Investor Relations, LHA Justin Hall – Chief Executive Officer and General Counsel Andy Jones – Chief Financial Officer Audrey Kunin – ...

NovaBay (NYSE:NBY): Q3 GAAP EPS of -$0.05 misses by $0.01. Revenue of $1.84M (-15.2% Y/Y) misses by $0.6M. Press Release For further details see: NovaBay EPS misses by $0.01, misses on revenue

DERMAdoctor acquisition significantly expands NovaBay’s presence in the large and lucrative skincare market DERMAdoctor transaction is immediately accretive to NovaBay’s earnings with expected profitability within one year Conference call begins at 4:30 p...

Company to hold third quarter 2021 earnings call on November 11 and will discuss plans for the combined companies NovaBay ® Pharmaceuticals, Inc. (NYSE American: NBY) announces the closing of the previously announced acquisition of DERMAdoctor, LLC. The Company ...

Private Placement allows Company to close on DERMAdoctor acquisition this week NovaBay ® Pharmaceuticals, Inc. (NYSE American: NBY) (“NovaBay” or the “Company”) announces the closing of a previously announced private placement for gross p...

Private Placement to fund acquisition of DERMAdoctor NovaBay ® Pharmaceuticals, Inc. (NYSE American: NBY) (“NovaBay” or the “Company”) announces it has entered into a Securities Purchase Agreement with certain institutional investors in c...